RxDoctor Payments Data

Eric Berkowitz

Clinical Cardiac Electrophysiology · Boca Raton, FLNPI 1508008806

Payments from drug & device makers

$16,136in general payments, 2019–2025

Across 260 payments — averaging $62.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Abbott$3K
  • Boston Scientific$2K
  • Biosense Webster, Inc.$905
  • Cardiva Medical, Inc.$298
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$268
  • plus $1K from 11 others

What the payments were for

  • Speaking & faculty fees$4,25026%
  • Travel & lodging$3,19120%
  • Food & beverage$8,69554%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,136 in reported general payments places this provider in the 25th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida

Medicare billing

Part B allowed, 2024
$907,229
Medicare patients
2,802
Services billed
8,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban243$222,952
MultaqDronedarone Hcl180$194,623
XareltoRivaroxaban51$44,997
Disopyramide Phosphate79$12,976
Mexiletine Hcl43$5,734
Dofetilide27$5,082
Propafenone Hcl ErPropafenone Hcl16$4,458
Flecainide Acetate104$4,311
Dabigatran EtexilateDabigatran Etexilate Mesylate18$3,289
Metoprolol Succinate186$2,788
Diltiazem 24hr Er (La)Diltiazem Hcl14$2,374
Bisoprolol Fumarate99$1,344
Amiodarone Hcl84$1,211
Midodrine Hcl14$1,030
Diltiazem 24hr Er (Cd)Diltiazem Hcl33$959

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$47$222,952243 claims
Sanofi-aventis U.S. LLCMultaq$150$194,623180 claims
Johnson & JohnsonXarelto$92$44,99751 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 249 clinical cardiac electrophysiology providers in Florida.

Other clinical cardiac electrophysiology in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →